Comorbidities in psoriasis.
Indian J Dermatol Venereol Leprol
;
2013 Jul; 79(Suppl_7):s10-s17
Artigo
em Inglês
| IMSEAR
| ID: sea-154739
ABSTRACT
Moderate to severe psoriasis is associated with concomitant diseases that may have a significant impact on patients. It is necessary for the treating physician to recognize these concomitant diseases, known as comorbidities, early as they influence the management options. Important comorbidities are psoriatic arthritis, metabolic syndrome, Crohn’s disease, depression, and cancer. Patients with severe psoriasis may be at an increased risk for myocardial infarction and this subgroup of patients tends to have a reduced life expectancy. The presence of co-morbid diseases is associated with an increase in concomitant medication, some of which may worsen psoriasis; conversely, systemic treatment of psoriasis with certain drugs may impact the co-morbid conditions. As dermatologists are the primary health-care providers for psoriasis, adequate knowledge of comorbidities helps in choosing the appropriate therapy as well as timely intervention.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Psoríase
/
Humanos
/
Doenças Cardiovasculares
/
Doença de Crohn
/
Comorbidade
/
Síndrome Metabólica
/
Fígado Gorduroso
/
Hepatopatia Gordurosa não Alcoólica
/
Longevidade
/
Transtornos Mentais
Tipo de estudo:
Estudo diagnóstico
Idioma:
Inglês
Revista:
Indian J Dermatol Venereol Leprol
Ano de publicação:
2013
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS